Sun Pharmaceutical Industries Limited (NSE:SUNPHARMA)
India · Delayed Price · Currency is INR 1,840.50
-20.50 (-1.10%)
Sep 11, 2026, 3:15 PM IST
NSE:SUNPHARMA Stock Forecast
Stock Price Forecast
According to 34 analysts polled by S&P Global, NSE:SUNPHARMA stock has a consensus rating of "Buy" and an average price target of ₹2,167. The average 1-year stock price forecast is 17.75% higher than the current stock price, while the lowest is ₹1,830 (-0.57%) and the highest is ₹2,400 (+30.40%).
Price Target: ₹2,167 (+17.75%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for NSE:SUNPHARMA stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 23 | 22 | 20 | 20 | 20 | 19 |
| Buy | 9 | 7 | 10 | 10 | 10 | 10 |
| Hold | 0 | 0 | 1 | 1 | 1 | 1 |
| Sell | 2 | 2 | 2 | 2 | 2 | 3 |
| Strong Sell | 2 | 1 | 1 | 1 | 1 | 1 |
| Total | 36 | 32 | 34 | 34 | 34 | 34 |
Financial Forecast
Revenue This Year
651.01B
from 584.62B
Increased by 11.36%
Revenue Next Year
729.02B
from 651.01B
Increased by 11.98%
EPS This Year
54.75
from 52.01
Increased by 5.26%
EPS Next Year
64.53
from 54.75
Increased by 17.87%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.